GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?

Hyperglycemia strongly affects endothelial function and activation, which in turn increases the risk of atherosclerotic cardiovascular disease. Among pharmacotherapies aimed at lowering blood glucose levels, glucagon-like peptide 1 receptor agonists (GLP-1RA) represent a class of drugs involved in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Menghini, Rossella, Casagrande, Viviana, Rizza, Stefano, Federici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520195/
https://www.ncbi.nlm.nih.gov/pubmed/37401947
http://dx.doi.org/10.1007/s00592-023-02124-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520195/
https://www.ncbi.nlm.nih.gov/pubmed/37401947
http://dx.doi.org/10.1007/s00592-023-02124-w

Ejemplares similares